Table 2.
Hazard ratios (HRs) and 95% confidence intervals (CIs) for associations with antimalarial exposure in pregnancy and fetal loss among active duty women in the United States military, 2003–2014.
| Exposure and timing | Total N | All fetal lossesa |
Spontaneous abortion |
||||||
|---|---|---|---|---|---|---|---|---|---|
| n | (%) | HRb | HR (95% CI)c | n | (%) | HRb | HR (95% CI)c | ||
| None (reference) | 197,835 | 34,889 | (17.6) | 1.00 | – | 30,030 | (15.2) | 1.00 | – |
| Atovaquone-proguanil | |||||||||
| Any exposure | 50 | 14 | (28.0) | 1.40 | 1.46 (0.87, 2.46) | 13 | (26.0) | 1.50 | 1.55 (0.90, 2.67) |
| First trimester exposure | 47 | 14 | (29.8) | 1.53 | 1.59 (0.94, 2.67) | 13 | (27.7) | 1.61 | 1.67 (0.97, 2.88) |
| Mefloquine | |||||||||
| Any exposure | 156 | 25 | (16.0) | 1.06 | 1.06 (0.72, 1.57) | 20 | (12.8) | 0.98 | 0.96 (0.62, 1.49) |
| First trimester exposure | 132 | 22 | (18.2) | 1.21 | 1.20 (0.80, 1.78) | 20 | (15.2) | 1.15 | 1.12 (0.72, 1.74) |
| Chloroquine | |||||||||
| Any exposure | 131 | 8 | (6.1) | 0.52 | 0.47 (0.24, 0.94) | 6 | (4.6) | 0.45 | 0.41 (0.18, 0.91) |
| First trimester exposure | 97 | 8 | (8.3) | 0.63 | 0.57 (0.29, 1.14) | 6 | (6.2) | 0.56 | 0.50 (0.23, 1.11) |
Includes spontaneous abortions, stillbirths, and other losses not identified as ectopic or molar pregnancies or elective abortions.
Model adjusted for maternal age at conception.
Model adjusted for maternal age at conception, service branch, rank, marital status, and exposure to vaccinations generally contraindicated in pregnancy.